Bruce Bartholow Duncan1, Elisabeth Barboza França2, Valéria Maria de Azeredo Passos3, Ewerton Cousin1, Lenice Harumi Ishitani4, Deborah Carvalho Malta5, Mohsen Naghavi6, Meghan Mooney6, Maria Inês Schmidt1. 1. Programa de Pós-graduação em Epidemiologia e Hospital de Clínicas de Porto Alegre da Universidade Federal do Rio Grande do Sul -Porto Alegre (RS), Brasil. 2. Programa de Pós-graduação em Saúde Pública da Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil. 3. Programa de Pós-graduação em Ciências do Adulto da Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil. 4. Secretaria Municipal de Saúde de Belo Horizonte - Belo Horizonte (MG), Brasil. 5. Departamento de Enfermagem Materno-Infantil e Saúde Pública da Escola de Enfermagem da Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil. 6. Institute for Health Metrics and Evaluation da University of Washington - Seattle (WA), Estados Unidos.
Abstract
INTRODUCTION AND OBJECTIVE: : The global burden of disease (GBD) 2015 project, extends GBD analyses to include Brazilian federative units separately. We take advantage of GBD methodological advances to describe the current burden of diabetes and hyperglycemia in Brazil. METHODS: : Using standard GBD 2015 methods, we analyzed the burden of diabetes, chronic kidney disease due to diabetes and high fasting plasma glucose in Brazil and its states. RESULTS: : The age-standardized rate of disability-adjusted life years (DALYs) which was lost to high fasting plasma glucose, a category which encompasses burdens of diabetes and of lesser hyperglycemia, were 2448.85 (95% UI 2165.96-2778.69) /100000 for males, and 1863.90 (95% UI 1648.18-2123.47) /100000 for females in 2015. This rate was more than twice as great in states with highest burden, these being overwhelmingly in the northeast and north, compared with those with lowest rates. The rate of crude DALYs for high fasting plasma glucose, increased by 35% since 1990, while DALYs due to all non-communicable diseases increased only by 12.7%, and DALYs from all causes declined by 20.5%. DISCUSSION:: The worldwide pandemic of diabetes and hyperglycemia now causes a major and growing disease burden in Brazil, especially in states with greater poverty and a lesser educational level. CONCLUSION: : Diabetes and chronic kidney disease due to diabetes, as well as high fasting plasma glucose in general, currently constitute a major and growing public health problem in Brazil. Actions to date for their prevention and control have been slow considering the magnitude of this burden.
INTRODUCTION AND OBJECTIVE: : The global burden of disease (GBD) 2015 project, extends GBD analyses to include Brazilian federative units separately. We take advantage of GBD methodological advances to describe the current burden of diabetes and hyperglycemia in Brazil. METHODS: : Using standard GBD 2015 methods, we analyzed the burden of diabetes, chronic kidney disease due to diabetes and high fasting plasma glucose in Brazil and its states. RESULTS: : The age-standardized rate of disability-adjusted life years (DALYs) which was lost to high fasting plasma glucose, a category which encompasses burdens of diabetes and of lesser hyperglycemia, were 2448.85 (95% UI 2165.96-2778.69) /100000 for males, and 1863.90 (95% UI 1648.18-2123.47) /100000 for females in 2015. This rate was more than twice as great in states with highest burden, these being overwhelmingly in the northeast and north, compared with those with lowest rates. The rate of crude DALYs for high fasting plasma glucose, increased by 35% since 1990, while DALYs due to all non-communicable diseases increased only by 12.7%, and DALYs from all causes declined by 20.5%. DISCUSSION:: The worldwide pandemic of diabetes and hyperglycemia now causes a major and growing disease burden in Brazil, especially in states with greater poverty and a lesser educational level. CONCLUSION: : Diabetes and chronic kidney disease due to diabetes, as well as high fasting plasma glucose in general, currently constitute a major and growing public health problem in Brazil. Actions to date for their prevention and control have been slow considering the magnitude of this burden.
Authors: Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro Journal: Arq Bras Cardiol Date: 2022-01 Impact factor: 2.000
Authors: Jessica L Castilho; Maria M Escuder; Valdiléa Veloso; Jackeline O Gomes; Karu Jayathilake; Sayonara Ribeiro; Rosa A Souza; Maria L Ikeda; Paulo R de Alencastro; Unai Tupinanbas; Carlos Brites; Catherine C McGowan; Alexandre Grangeiro; Beatriz Grinsztejn Journal: J Int AIDS Soc Date: 2019-01 Impact factor: 6.707
Authors: Rafael Alves Guimarães; Otaliba Libânio de Morais Neto; Marta Rovery de Souza; Juan José Cortez-Escalante; Thays Angélica de Pinho Santos; Claci Fátima Weirich Rosso; Márcio Mangueira Pacheco; Jamesson Ferreira Leite Júnior; Guthardo Sobrinho França; Lilia de Jesus Fonseca; Ludmila Grego Maia Journal: Int J Environ Res Public Health Date: 2018-12-25 Impact factor: 3.390
Authors: Diego Augusto Santos Silva; Mohsen Naghavi; Bruce B Duncan; Maria Inês Schmidt; Maria de Fatima Marinho de Souza; Deborah Carvalho Malta Journal: Diabetol Metab Syndr Date: 2019-02-28 Impact factor: 3.320
Authors: Elisabeth B França; Valéria Maria de Azeredo Passos; Deborah Carvalho Malta; Bruce B Duncan; Antonio Luiz P Ribeiro; Mark D C Guimarães; Daisy M X Abreu; Ana Maria N Vasconcelos; Mariângela Carneiro; Renato Teixeira; Paulo Camargos; Ana Paula S Melo; Bernardo L Queiroz; Maria Inês Schmidt; Lenice Ishitani; Roberto Marini Ladeira; Otaliba L Morais-Neto; Maria Tereza Bustamante-Teixeira; Maximiliano R Guerra; Isabela Bensenor; Paulo Lotufo; Meghan Mooney; Mohsen Naghavi Journal: Popul Health Metr Date: 2017-11-22